Cardiovascular and Renal Drugs Advisory Committee Roster
Applying for Membership on FDA Advisory Committees
As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)
Current Number of Vacancies = 2
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
A. Michael Lincoff, M.D.
Expertise: Cardiovascular Disease/Interventional Cardiology
Term: 10/24/2011 – 6/30/2015
Director, Cleveland Clinic Coordinating Center for Clinical Research (C5Research)
Vice Chairman, Department of Cardiovascular Medicine and Lerner Research Institute
Professor of Medicine
9500 Euclid Avenue
Cleveland, Ohio 44195
|Designated Federal Officer|
Kristina A. Toliver, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
James A. de Lemos, M.D.
Scott Emerson, M.D., Ph.D.
Linda F. Fried, M.D., M.P.H.
Julia B. Lewis, M.D.
Jennifer S. Li M.D., MHS
Vasilios Papademetriou, M.D., F.A.C.C., F.A.H.A.
Stuart Rich, M.D.
Philip Sager, M.D., F.A.C.C., F.A.H.A.
**Rob Scott, M.D.
Persons with disabilities having problems accessing the PDF files may call (301) 796-3634 for assistance.